Louisiana House Bill Clarifies Drug Dealer Liability for Hemp Sales to Minors

May 28, 2025 | 2025 Legislature LA, Louisiana


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Louisiana House Bill Clarifies Drug Dealer Liability for Hemp Sales to Minors
The Louisiana Senate Judiciary A Committee convened on May 28, 2025, to discuss House Bill 36, which aims to strengthen the Drug Dealer Liability Act. The bill clarifies that selling consumable hemp products outside the established legal framework constitutes selling a controlled dangerous substance, thereby exposing sellers to civil liability if harm occurs. This legislation is particularly focused on protecting minors from the dangers of unregulated hemp products.

Representative Schlegel, the bill's sponsor, emphasized that the legislation is a necessary step to hold accountable those who sell hemp products to minors, a growing concern in Louisiana. The bill aims to address the alarming trend of adolescents consuming high-potency hemp-derived products, which can lead to serious health issues, including increased anxiety and impulsivity. Dr. Joseph Jones, a forensic toxicologist, supported the bill, citing scientific evidence of the risks associated with cannabinoid exposure during adolescence.

During the meeting, concerns were raised about the potential implications of the bill on legitimate businesses. Jessica Starnes, representing Crescent Distributions, argued that the bill could inadvertently label compliant businesses as drug dealers for minor regulatory violations. She highlighted that Louisiana already has stringent regulations governing the hemp industry, and the proposed changes could lead to excessive litigation against businesses striving to comply with the law.

The committee discussed the need for a balanced approach that protects youth while not unduly punishing responsible businesses. Some members suggested that the bill could be amended to focus solely on sales to minors, rather than encompassing all regulatory violations under the Drug Dealer Liability Act.

The committee's deliberations reflect a broader concern about the regulation of hemp products in Louisiana, as lawmakers seek to navigate the complexities of public health and business interests. The next steps for House Bill 36 will involve further discussions and potential amendments to address the concerns raised during the meeting.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting

Comments

    Sponsors

    Proudly supported by sponsors who keep Louisiana articles free in 2025

    Scribe from Workplace AI
    Scribe from Workplace AI